Join the Oncology Voice Network. Join for Free
MSL Onboarding, Training and the first 60 days with Maria Urso
MSL onboarding MSL training pharma career MSL exam preparation qualities of MSLs

MSL Onboarding, Training and the first 60 days with Maria Urso


Share This Article


Summary

In this episode, my guest is Maria Urso. Maria is the Associate Director of MSLs for Exact Sciences. We talk about MSL onboarding, training, and the first 60 days as an MSL in addition to some other things.

In this episode:

  • How Maria ended up in pharma
  • Maria’s view on the onboarding, training, and the exam
  • Advice for MSLs to help them get prepared for onboarding
  • What can someone expect from a day-to-day perspective
  • How important is it to follow the syllabus
  • What materials to expect
  •  How to stay focused while having the syllabus
  • How to prepare for the exam
  • The presentation on the exam and the interview
  • What qualities Maria look for in MSLs
  •  Crazy interview stories 
  • Advice for someone who's trying to break into the industry
  • Final advice for someone who is about to start their onboarding or about finish or going out into the field

Click for Source
MSL onboarding, MSL training, pharma career, MSL exam preparation, qualities of MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Podcast
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Partner Avatar MSL Talk: Tom Caravela, John Caskey

Prepare to LAUNCH: How to Build an MSL Team From Scratch

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Explore OVN